Amélie Lothe

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Traumatic Brain Injury

Tyrosine Kinase

Lipopolysaccharide Induced

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Gil-Nagel, Judith Helen Cross, Orrin Devinsky, Berten Ceulemans, Lieven Lagae, Kelly G Knupp, An-Sofie Schoonjans, Philippe Ryvlin, Elizabeth A Thiele, Shikha Polega, Amélie Lothe, Rima Nabbout
Comprehensive scoping review of fenfluramine's role in managing generalized tonic-clonic seizures in developmental and epileptic encephalopathies. Epilepsia (2024)
Antonio Gil-Nagel, Judith Helen Cross, Orrin Devinsky, Berten Ceulemans, Lieven Lagae, Kelly G Knupp, An-Sofie Schoonjans, Philippe Ryvlin, Elizabeth A Thiele, Shikha Polega, Amélie Lothe, Rima Nabbout
Comprehensive scoping review of fenfluramine's role in managing generalized tonic-clonic seizures in developmental and epileptic encephalopathies. Epilepsia 65 (8) (2024)
Antonio Gil-Nagel, Judith Helen Cross, Orrin Devinsky, Berten Ceulemans, Lieven Lagae, Kelly G Knupp, An-Sofie Schoonjans, Philippe Ryvlin, Elizabeth A Thiele, Shikha Polega, Amélie Lothe, Rima Nabbout
Comprehensive scoping review of fenfluramine's role in managing generalized tonic-clonic seizures in developmental and epileptic encephalopathies. Epilepsia 65 (8) (2024)
John Cha, Gregory Filatov, Steven J Smith, Arnold R Gammaitoni, Amélie Lothe, Thadd Reeder
Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome. Epilepsia open (2023)